Single-wavelength fluorescent reporters allow visualization of specific neurotransmitters with high spatial and temporal resolution. We report variants of intensity-based glutamate-sensing fluorescent reporter (iGluSnFR) that are functionally brighter; detect submicromolar to millimolar amounts of glutamate; and have blue, cyan, green, or yellow emission profiles. These variants could be imaged in vivo in cases where original iGluSnFR was too dim, resolved glutamate transients in dendritic spines and axonal boutons, and allowed imaging at kilohertz rates.
Although the affinity of iGluSnFR is adequate for some in vivo applications, faster off-rate variants are needed to resolve fast glutamate transients associated with local glutamate release. Mutation of S72 in the glutamate-binding pocket to alanine resulted in a soluble protein (SF-iGluSnFR.S72A) with a slower on-rate, faster offrate, and 200 µ M affinity for glutamate ( Supplementary Fig. 4a,b ). The affinity of Venus-flytrap-like binding proteins can be altered without compromising the stereochemical integrity of the ligandbinding site through mutations in the 'hinge' region and allosteric shifting of open and ligand-free to closed and ligand-bound equilibrium 11 . We screened a saturating A184X library of SF-iGluSnFR (A184V in original iGluSnFR). Reversion to alanine or other small amino acids increased affinity (A184A had a low ∆ F/F), whereas larger side chains decreased affinity ( Supplementary Fig. 4c ). A184S had a slower off-rate and showed an increase in affinity from 40 µ M (A184V) to 7 µ M (A184S; Supplementary Fig. 4a,b) .
We recloned these SF-iGluSnFR variants (S72A (low affinity), A184V (original), and A184S (high affinity)) into an adeno-associated virus vector containing an IgG secretion signal and a PDGFR transmembrane domain. Expression of the membrane-tethered version in cultured rat hippocampal neurons increased its affinity by an order of magnitude ( Supplementary Fig. 5a ), as was observed with the original sensor 1 . Whole-field electrical stimulation (50 Hz) of neuronal cultures expressing SF-iGluSnFR variants increased fluorescence, with decay rates that paralleled the in vitro kinetics; all variants decayed faster than the calcium sensor GCaMP6f ( Supplementary Fig. 5b) . A recently published iGluSnFR.S72T variant also has a fast off-rate (ref. 12 ), but SF-iGluSnFR.S72T showed a lower ∆ F/F than S72A in our hands.
In vivo, the high-affinity SF-iGluSnFR.A184S variant improved detection of stimulus-evoked glutamate release in ferret visual cortical neuropil in response to drifting gratings (Fig. 1 ). In neuropil, peak amplitudes reached 30% ∆ F/F for SF-iGluSnFR.A184S (Fig. 1a -c) but only 5% ∆ F/F for SF-iGluSnFR.A184V ( Supplementary Fig. 6 ), and were not apparent with original iGluSnFR (data not shown). We also saw detectable, but lower-magnitude, changes in fluorescence on cell bodies with SF-iGluSnFR.A184S (Fig. 1a-c) . The greater ∆ F/F of SF-iGluSnFR.A184S allowed extraction of robust orientation tuning curves in regions of sparse labeling ( Fig. 1d, Supplementary Fig. 7 ). We were also able to resolve orientation-selective responses in individual dendritic spines, with some spillover onto nearby dendrites (Fig. 1e,f) . Some individual spines showed robust orientation selectivity (Fig. 1g ), whereas other spines on the same dendrite exhibited little or no visually driven activity ( Supplementary Fig. 7c ). The response magnitude at spines was stable over multiple stimulus presentations, with no appreciable loss in fluorescence intensity or ∆ F/F ( Supplementary  Fig. 8 ). We found that response amplitudes across individual trials were consistently greater in the A184S variant than in the A184V variant ( Supplementary Fig. 6 ) when we considered all stimulus-evoked responses (A184S, median ∆ F/F = 16%, n = 72 spines; A184V, median ∆ F/F = 9%, n = 22 spines; P < 0.0001, Wilcoxon rank-sum test) or only preferred stimuli (A184S, median ∆ F/F = 27%, n = 72; A184V, median ∆ F/F = 14%, n = 22; P < 0.0001; Supplementary Fig. 7b ). Single-trial responses from individual spines showed clear orientation selectivity and displayed robust glutamate events with high signal-to-noise ratio (SNR; Supplementary Fig. 7d,e, Supplementary Video 1) .
The faster off-rate of SF-iGluSnFR.S72A enabled more accurate quantification of quantal synaptic responses at high stimulation frequencies than is possible with SF-iGluSnFR.A184V or original iGluSnFR ( Fig. 2a,b, Supplementary Fig. 9 ). We modulated transmitter release and its temporal depression by changing the extracellular calcium concentration 13 . SF-iGluSnFR.A184V and original iGluSnFR could not distinguish the differences in the temporal pattern of transmitter release between 1 mM and 3.5 mM Ca 2+ during a brief stimulus train (20 Hz) . In contrast, S72A reported the conversion from facilitation of individual responses during the stimulus train to a strong depression after a switch from low to high extracellular Ca 2+ concentration ( Fig. 2c ). This makes SF-iGluSnFR.S72A more useful for assessing short-term synaptic plasticity. S72A also enhanced the spatial resolution of glutamate release compared with that achieved with A184V ( Supplementary Fig. 10 ).
We next examined whether SF-iGluSnFR could be used as an alternative to GCaMP6f to monitor the presynaptic activity of granule cell axons within mouse cerebellar brain slices. Axons of granule cells bifurcate in the molecular layer of the cerebellar cortex to form parallel fibers (PFs; Fig. 2d ), which can be reliably stimulated by local extracellular methods 14 . We detected single-action-potential (AP)-evoked fluorescence from SF-iGluSnFR.A184V in individual PF boutons by fast line-scan two-photon imaging (~1 ms per line; Fig. 2e ,f). Not all stimuli evoked fluorescence changes, as expected when the probability of vesicle fusion is low and there are few release sites 15 . This silence was not due to AP initiation failure, as our stimulation protocol reliably produced axonal Ca 2+ transients ( Supplementary Fig. 11 ). SF-iGluSnFR. A184V showed faster rise and decay times than GCaMP6f in 2 mM extracellular calcium ([Ca 2+ ] e ; Fig. 2f , Supplementary Fig. 12a ). S72A was even faster (decay half-times: S72A, 10.6 ± 1.4 ms; A184V, 29.1 ± 1.8 ms; GCaMP6f, 111.4 ± 6.7 ms; Supplementary Fig. 12a ). The SNRs were highest for A184V ( Fig. 2g ). GCaMP6f bouton fluorescence accumulated during 20 Hz stimulation, whereas both A184V and S72A produced distinct responses that returned to baseline ( Fig. 2h , Supplementary Fig. 12b ), similar to dendritic responses in culture ( Fig. 2a ). As the average of three to ten fluorescence traces from a single bouton would have noise similar to that of three to ten boutons averaged in one trial ( Fig. 2e ), we suggest that presynaptic APs could be inferred from SF-iGluSnFR responses. We analyzed population averages to demonstrate that SF-iGluSnFR variants were sufficiently fast to report single events even in response to 100 Hz stimulation, in contrast to GCaMP6f ( Fig. 2h, Supplementary Fig. 12c ). Therefore, provided that a sufficient number of boutons from the same axon could be recorded simultaneously, SF-iGluSnFR, unlike GCaMP6f, could allow the detection of PF firing frequencies typical of the high instantaneous firing rates (> 100 Hz) of cerebellar granule cells 16 .
The introduction of chromophore mutations from GFP variants Azurite, mTurquoise2, and Venus to SF-iGluSnFR led to blue, cyan, and yellow versions, respectively ( Supplementary Fig. 13 ). For SF-Azurite-iGluSnFR and SF-mTurquoise2-iGluSnFR, reoptimization was required in order to increase ∆ F/F ( Supplementary Fig. 14) . SF-Venus-iGluSnFR was a straightforward modular replacement with similar affinity and maximum fluorescence response as SF-iGluSnFR, but with red-shifted excitation and emission spectra ( Supplementary Fig. 14) . Its two-photon excitation spectrum allowed strong excitation at 1,030 nm ( Supplementary  Fig. 14) , compatible with powerful femtosecond fiber lasers 17 . The high output power of fiber lasers allows for simultaneous excitation of many foci, thus enabling fast (1,016 Hz) imaging of large areas 18 . In neuronal culture, we were able to resolve two nearsimultaneous pulses of uncaged glutamate with both high spatial and high temporal resolution in a neuron expressing SF-Venus-iGluSnFR.A184V (Fig. 3a,b and Supplementary Video 2). The propagation of fluorescence through the sample was consistent with diffusion of glutamate ( Fig. 3c ). In mouse visual cortex, we recorded single-spine fluorescence transients from sparsely expressed SF-Venus-iGluSnFR.A184S in response to moving gratings ( Fig. 3d , Supplementary Video 3). We detected strongly orientation-selective spines ( Fig. 3e ) with minimal signal response from adjacent dendritic segments. SNR was sufficient to detect orientation-selective responses in single trials (Fig. 3f ).
The SF-iGluSnFR variants described here could increase the power of genetically encoded glutamate imaging. Affinity variants with altered kinetics broaden the dynamic and concentration ranges of observable glutamate transients. Chromatic mutants allow fast imaging with lower-cost lasers, and open a path to multicolor imaging in conjunction with other probes. In all applications, improvements in membrane targeting and photostability will increase precision, especially in complex tissues such as brain neuropil, where synapses outnumber neurons by a factor of thousands. We expect that together, these variants will substantially increase the potential of glutamate imaging to monitor brain function.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41592-018-0171-3. Traces were scaled to the maximal response for clarity. d-g, Results in cerebellar granule cell boutons. d, Two-photon fluorescence image of granule cells (arrows) and axonal boutons (dotted circle) expressing SF-iGluSnFR.A184V in an acute brain slice. GL, granular layer; ML, molecular layer. e, Single trials (red) and mean traces (blue, average of 3 trials; black, average of 10 trials) of SF-iGluSnFR.A184V responses to 20-Hz extracellular stimulation. Similar results were obtained in 11 boutons. f, Normalized averaged fluorescence traces from single boutons expressing GCaMP6f (GC6f; black; 2 mM [Ca 2+ ] e ), SF-iGluSnFR.A184V (A184V; red; 1.5 mM [Ca 2+ ] e ), and SF-iGluSnFR.S72A (S72A; blue; 1.5 mM [Ca 2+ ] e ) in response to single APs. Results were repeated in multiple boutons: n = 10, GC6f; n = 12, A184V; and n = 7, S72A. g, Summary plot of SNR (mean ± s.d.; n = 7 boutons for GC6f, 12 for A184V, and 7 for S72A). **P = 0.0033, ## P = 0.0096. Multiple comparisons were performed with the Kruskal-Wallis test and Dunn's multiple-comparisons test. h, Population-averaged response at the same calcium concentration (1.5 mM [Ca 2+ ] e ) to 20-Hz stimulation, normalized to the peak of the first response (left; n = 5 boutons for GC6f; n = 17, A184V; n = 6, S72A), and to 100 Hz, normalized to the maximum amplitude (middle; n = 9 boutons for GC6f, A184V, and S72A) or to the peak of the first response (right; n = 9 boutons for A184V and for S72A). Black arrows indicate 60-µ s extracellular voltage pulse times. 
Methods
In vivo assessment of iGluSnFR brightness and photostability in apical dendrites in mouse somatosensory cortex. All procedures were approved by the Janelia Institutional Animal Care and Use Committee and Institutional Biosafety Committee. Wild-type C57BL/6J mice were purchased from the Jackson Laboratory and group-housed in the Janelia animal facility. Mice (male and female) were injected at 8 weeks of age with AAV2/1.hSynapsin1.iGluSnFR.A184S or SF-iGluSnFR.A184S, at identical titers (1 × 10 13 genomic copies (GC)/ml), volumes (20 nl), and locations (3 mm lateral to midline, 1.4 mm caudal to bregma, and 0.3 mm below the cortical surface). After viral injection, a craniotomy (3-mm diameter) was made over the injection site, and the removed portion of the skull was replaced with a #1.5 Schott glass fixed in place with dental acrylic (Lang Dental Manufacturing), which also secured a titanium head bar to the skull for headmounting during imaging experiments. In vivo two-photon imaging experiments were performed while the mice were in a state of 'quiet wakefulness' , after they had been habituated to head fixation over the prior 2-3 d. Periodic water rewards were given to keep animals hydrated and passive. For comparisons of intensity and bleaching, we used a custom two-photon microscope emitting 960-nm light from a Coherent Chameleon ultrafast laser. All experiments were performed with a 25× /1.05-NA (numerical aperture) Olympus objective immersed in water. Image acquisition was performed with ScanImage (Vidrio) software and analyzed post hoc with ImageJ (NIH). We acquired images at a variety of speeds, zooms, and powers to assess the effects of pulse energy and dwell time on bleaching and intensity. Images at each setting were acquired for 5 s. For data analysis, images were averaged and thresholded to create a signal (above threshold) and background mask. Signals in these masks were then averaged, and SNR was calculated from these as (signal -background)/(s.d. of background). The bleaching percentage was calculated as the average intensity in the first 25% of the trace, divided by the last 25% of the trace.
Mouse retinal explant imaging for assessment of iGluSnFR brightness and photostability.
Retinas were prepared via established methods 19 . iGluSnFR was expressed in retinal neurons after injection of 0.8-1.0 µ l of AAV2/1.hSynapsin1 virus (1 × 10 13 GC/ml) into the vitreous humor of adult mouse eyes using a customdesigned syringe (Borghuis Instruments, New Haven, CT). After 17-21 d, eyes were dissected in oxygenated Ames medium (95% O 2 , 5% CO 2 ; Sigma-Aldrich) under infrared illumination (OWL Night Vision Scopes, third generation; B. E. Meyers), and each retina was removed from the sclera and mounted photoreceptorside down on nitrocellulose paper with apertures for visual stimulation of the photoreceptors. Tissues were placed in a recording chamber on a custom-built twophoton fluorescence microscope (Olympus BX-51) and continuously perfused with oxygenated Ames medium at physiological temperature (~6 ml/min; 34-36 °C). Two-photon fluorescence measurements were made with ScanImage software v3.6 (https://www.scanimage.org) 20 using an Olympus 60× /1.0-NA LUMPlanFl/ IR objective and an ultra-fast pulsed laser (Chameleon Vision II; Coherent) tuned to 927 nm. Images (512 × 128 pixels) were acquired at 16 frames per second; line scans were obtained at 2 kHz and downsampled (box-car average) to 500 Hz for presentation in Supplementary Fig. 3 . Visual stimuli were generated with an Apple iMac computer using Matlab (The MathWorks) and the Psychophysics Toolbox (http://psychtoolbox.org). Stimuli were displayed using a modified LED digital light processing video projector (HP AX325AA Notebook Projection Companion; Hewlett-Packard Co.) with a single near-UV LED (NC4U134A; λ max = 395 nm; Nichia Co., Japan). The projected image was miniaturized and focused onto the retinal photoreceptor layer with the microscope condenser. A 440-nm shortpass dichroic filter (Semrock Inc., Rochester, NY) prevented stimulus light from reaching the photon multiplier tubes. Image size on the retina was 2.1 × 2.8 mm; irradiance was 0.1 mW/cm 2 . Data were analyzed with custom algorithms in Matlab.
Assessment of SF-iGluSnFR.A184S and A184V in ferret visual cortex. All procedures were approved by the Max Planck Florida Institute for Neuroscience Institutional Animal Care and Use Committee and adhered to the standards of the National Institutes of Health. Juvenile female ferrets (Mustela putorius furo; Marshall Farms) were used. Animals were housed in a vivarium under a 16-h light/8-h dark cycle. The full methodological details for functional two-photon imaging of ferret visual cortex are given in ref. 21 .
Briefly, juvenile female ferrets at postnatal day (P) 21-22 (n = 2) were anesthetized with ketamine (50 mg/kg intramuscular injection) and isoflurane (1-3%) delivered in O 2 , then intubated and artificially respirated. Atropine (0.2 mg/kg) and a 1:1 mixture of lidocaine and bupivacaine were administered subcutaneously in the scalp. Animals were kept at 37 °C. A small craniotomy (0.8 mm) was made over primary visual cortex 7-8 mm lateral and 2-3 mm anterior to lambda. AAV2/1.hSynapsin1.Cre (Penn Vector Core) was diluted in phosphate-buffered saline (Sigma) and mixed with AAV2/1.hSynapsin1-FLEX. SF-iGluSnFR.A184S or A184V for expression in layer 2/3 cortical neurons. We lowered beveled glass micropipettes into the brain and injected 400-500 nl of virus over 5 min at multiple depths below the pia. Subsequently, the craniotomy was filled with 1% (w/v) agarose.
After 4 weeks, ferrets were anesthetized with 50 mg/kg ketamine and 1-3% isoflurane. Atropine (0.2 mg/kg) and bupivacaine were administered subcutaneously. Animals were kept at 37-38 °C, artificially respirated, and given intravenous fluids. Isoflurane (1-2%) was used throughout the surgical procedure to maintain a surgical plane of anesthesia. Electrocardiographs, endtidal CO 2 , external temperature, and internal temperature were continuously monitored. A custom titanium head plate was implanted on the skull at the viral injection site, and the dura was retracted to reveal the cortex. A custom insert with a single 5-mm coverslip (0.17-mm or 0.7-mm thickness) was placed onto the brain to gently compress the underlying cortex and dampen biological motion during imaging. The cranial window was hermetically sealed using a stainless-steel retaining ring and Vetbond. Tropicamide ophthalmic solution and phenylephrine hydrochloride ophthalmic solution were applied and contact lenses were inserted into both eyes. Upon completion of the surgical procedure, isoflurane was gradually reduced and pancuronium (2 mg/kg/h) was delivered intravenously to immobilize the animal.
The animal was placed under the microscope 25 cm from the stimulus monitor, with the monitor subtending 130° in azimuth and 74° in elevation. Imaging was carried out with a Bergamo II (Thorlabs) running ScanImage 5 or ScanImage 2015 20 (Vidrio Technologies) with dispersion-compensated 950-nm excitation provided by an Insight DS+ (Spectraphysics). Average excitation power after the exit pupil of the objective (16× ; CFI75; Nikon Instruments) ranged from 25 to 40 mW. Two-photon frame triggers from ScanImage were synchronized with stimulus information using Spike2 (CED). Visual stimuli were generated with PsychoPy 22 . Full-field drifting square-wave gratings (16 directions, 100% contrast, 0.1 cycles/degree, 4 cycles/s, 3-s stimulus period followed by 2-3-s interstimulus interval, plus a blank) were presented to the contralateral eye in a pseudorandom sequence for eight to ten trials.
Images were corrected for in-plane motion via a correlation-based approach (MATLAB). Regions of interests (ROIs) were drawn in ImageJ 23 . Fluorescence time courses were computed as the mean of all pixels within the ROI at each time point and were extracted with Miji 24 . Fluorescence time courses were then synchronized with stimulus information, and visually evoked responses were computed as changes in fluorescence relative to the baseline fluorescence. Peak Δ F/F responses for field ROIs and dendritic spine ROIs were computed by Fourier analysis to calculate mean and modulation amplitudes for each stimulus presentation, which were summed together.
For identification of spine SF-iGluSnFR events, Δ F/F traces during individual stimulus trials were smoothed with an exponentially weighted moving average filter (MATLAB), and peaks of possible Δ F/F events were identified. Peak amplitudes were compared to the s.d. of baseline spine fluorescence values. Identified spine events were those with a peak amplitude greater than the background fluorescence fluctuations by 1, 2, or 3 s.d.
Mouse neuronal culture analysis. Primary hippocampal neuron cultures. Primary hippocampal neuron cultures were prepared from embryonic mice (embryonic day 16) as described previously 25 . Hippocampi were rinsed three to five times in Hank's Balanced Salt Solution (HBSS; Life Technologies) and digested with trypsin (25 mg/ml; Life Technologies) for 20 min at 37 °C followed by DNase I (1 mg/ml; Roche). Subsequently, the tissue was triturated using cannulas (three times at 0.9 mm × 40 mm; three times at 0.45 mm × 23 mm) and the solution was passed through a nylon cell strainer (100 µ m; BD Biosciences). The mesh was rinsed with 4-10 ml of basal medium Eagle (Life Technologies) supplemented with 0.5% glucose (Sigma-Aldrich), 10% FCS, 2% B-27, and 0.5 mM l-glutamine (all Life Technologies) to collect all cells. After counting, the cells were plated on coverslips in a 24-well cell culture plate at a density of 70,000 cells per 24-well plate and cultured in a humidified incubator at 37 °C and 5% CO 2 .
Viral vector production. Recombinant AAV2/1 genomes were generated by largescale triple transfection of HEK293 cells as described previously 1 . The adenoassociated virus (AAV) plasmid coding for SF-iGluSnFR.S72A or SF-iGluSnFR. A184V, helper plasmids encoding rep and cap genes (pRV1 and pH21), and adenoviral helper pFΔ 6 (Stratagene) were transfected via the calcium phosphate transfection method. Cells were harvested ~72 h after transfection. To purify the virus, we lysed cell pellets in the presence of 0.5% sodium deoxycholate (Sigma) and 50 units/ml Benzonase endonuclease (Sigma). rAAV viral particles were purified from the cell lysate by HiTrap heparin HP column purification (GE Healthcare) and then concentrated using Amicon Ultra centrifugal filters (Millipore) until a final stock volume of 500 µ l was reached.
Viral transduction and image acquisition. Primary hippocampal neurons were transduced with AAV2/1.hSynapsin1.SF-iGluSnFR.S72A or AAV2/1.hSynapsin1. SF-iGluSnFR.A184V at 4 days in vitro (DIV) and imaged on DIV 13. A lowamplitude field stimulation (1 ms, 20 mA; platinum bar electrodes) was applied to recruit a small fraction (~20%) of neurons. Images were acquired with an EM-CCD (electron-multiplying charge-coupled device) camera (frame time: 5-50 ms) and a stabilized LED light source of cultures visualized through a coverslip with a high-NA objective (Zeiss; 63× /1.4-NA, water). All experiments were performed in Tyrode's solution (1 ml/min) at room temperature. Low-and high-affinity versions of SF-iGluSnFR were expressed in a similar manner.
Localization of glutamate-release sites. Primary hippocampal neurons were transduced with AAV2/1.hSynapsin1.SF-iGluSnFR.S72A or AAV2/1.hSynapsin1. SF-iGluSnFR.A184V on DIV 3-5 and used for experiments on DIV 13-18. A low-amplitude electrical field stimulation (1 ms, 20 mA; platinum bar electrodes) was applied to activate a small fraction (~20%) of neurons only. Per experiment, stimuli were applied 16-25 times at an interstimulus interval of 20-60 s. Images were acquired with an EM-CCD camera (Hamamatsu ImagEM X1; 8-ms exposure, 125-Hz acquisition rate) attached to an inverted microscope (Nikon T1 Eclipse) using a triggered, stabilized LED light source (Cairn OptoLED with 470-nm excitation wavelength, 470/40 emission filter and 525/50 excitation filter). Cells were imaged through a coverslip with a high-NA objective (Zeiss; 63× /1.4-NA, water). All experiments were performed in saline (1 ml/min, as described above) at room temperature.
In each experiment 30 images were acquired per stimulation trial (20 before and 10 after stimulation). Each of the 30 images was registered to the first image with the StackReg plugin in ImageJ. The image series was then normalized to the average of five frames before stimulation to distinguish responding sites (> 1) and nonresponding structures (~1). For the selection of responding sites to be included in the analysis, ten normalized images subsequent to the stimulus in the first trial were averaged. All spots of increased fluorescence ( Supplementary Fig. 10c,d ) that reached at least 50% of the ∆ F/F value of the brightest spot in the image were defined as responding sites and used for further analysis. We quantified the spatial extent of glutamate-release sites by extracting a brightness profile based on a line (length, 12-30 pixels; width, 3 pixels) drawn along the underlying neurite. These profiles were calculated for each stimulation trial and each responding site in an experiment and fitted by Gaussians with Igor Pro 6.3 (Wavemetrics).
In each experiment (n = 6 and 8 for S72A and A184V, respectively, each consisting of 16-25 trials) the mean deviation of the center (X 0 position), the average width and the average amplitude of the fitted Gaussians were calculated per response site and averaged across all experiments and statistically compared by unpaired Mann-Whitney test (n = 28 and 53 for S72A and A184V, respectively).
Cerebellar granule cell axon experiments and analysis.
All protocols were approved by the ethics committee CEEA-Paris1.
Stereotaxic injections.
To fluorescently label boutons of parallel fibers, we administered stereotaxic injections of viral vectors expressing SF-iGluSnFR or GCaMP6f into cerebellar vermis. We used the following vectors: AAV-DJ.hSynapsin1.SF-iGluSnFR (1.9 × 10 13 GC/ml), AAV2/1.hSynapsin1.SF-iGluSnFR. S72A (2.6 × 10 13 GC/ml), AAV-DJ.CAG.FLEX.SF-iGluSnFR.S72A (6.3 × 10 12 GC/ml) and AAV-DJ.hSynapsin1.GCaMP6f (1.2 × 10 13 GC/ml). Mice between 30 and 60 d old (male and female) were deeply anesthetized before surgery with a mixture of hypnotic (ketamine 1.5%; Mérial) and analgesic (xylazine 0.05%; Bayer) anesthetics mixed in NaCl and injected into the peritoneum. A local topical anesthetic (xylocaine 2% gel; Newpharma) was applied to the location of the cranial incision. The anesthetized mouse was then placed on a stereotaxic frame adaptor comprising adjustable ear bars and tooth holder. The skull was then perforated at the injection site with a surgical drill. The vermis was identified by comparison with the Paxinos and Franklin mouse brain atlas. The injection of viral constructs in the vermis (100 nl; 6.5 mm caudal to bregma, lateral 0.2 mm, ventral 3.6 mm and 3.4 mm) was performed by slow infusion (100 nl/min) with steel needles (26-gauge × 50 mm, and 36-gauge × 70 mm; Phymep) connected to a pump via a catheter and a Hamilton syringe. Injected mice were then kept 2-4 weeks to allow transgene expression.
Slice preparation. All protocols were approved by the ethics committee CEEA-Paris1. Cerebellar acute slices were prepared from adult CB6F1 mice (F1 cross of BalbC and C57BL/6J) or Gabra6 mice (B6;129P2-Gabra6 tm2(cre)Wwis /Mmucd) at postnatal day 41-123. The mice were killed by rapid decapitation, after which the brains were quickly removed and placed in an ice-cold solution containing (in mM) 2.5 KCl, 0.5 CaCl 2 , 4 MgCl 2 , 1.25 NaH 2 PO 4 , 24 NaHCO 3 , 25 glucose, 230 sucrose, and 0.5 ascorbic acid bubbled with 95% O 2 and 5% CO 2 . Coronal slices were cut from the dissected cerebellar vermis with a vibratome (Leica VT1200S). After preparation, the slices were incubated at 32 °C for 30 min in the following solution (in mM): 85 NaCl, 2.5 KCl, 0.5 CaCl 2 , 4 MgCl 2 , 1.25 NaH 2 PO 4 , 24 NaHCO 3 , 25 glucose, 75 sucrose, and 0.5 ascorbic acid. Slices were then transferred to an external recording solution containing (in mM) 125 NaCl, 2.5 KCl, 1.5 or 2.0 CaCl 2 , 1.5 or 1.0 MgCl 2 , 1.25 NaH 2 PO 4 , 25 NaHCO 3 , 25 glucose, and 0.5 ascorbic acid and maintained at room temperature for up to 6 h. All slice recordings were performed at 36-38 °C. In some GCaMP6f experiments 2 mM Ca 2+ was used to yield singlestimulus events with sufficient signal-to-noise to measure rise and fall dynamics ( Fig. 2f,g, Supplementary Fig. 12a ); otherwise 1.5 mM was used to match the [Ca 2+ ] used for all SF-iGluSnFR. The lower concentration also helped to minimize GCaMP saturation during trains (Fig. 2h) .
Transmitted light and fluorescence imaging. Parallel fiber boutons expressing SF-iGluSnFR or GCaMP6f or loaded with Fluo-5F were identified using an Ultima two-photon scanning scanhead (Bruker Nano Surfaces Division, Middleton, WI, USA) that was mounted on an Olympus BX61W1 microscope equipped with a water-immersion objective (60× /1.1-NA; Olympus Optical, Tokyo, Japan) and infrared Dodt-gradient contrast. Two-photon excitation was performed with a pulsed Ti:Sapphire laser (DeepSee, Spectra-Physics, France) tuned to 920 nm for imaging morphology, glutamate, and Ca 2+ fluorescence from genetic probes, and 840 nm for excitation of Fluo-5F (Chameleon, Coherent, USA).
Extracellular PF axonal stimulation was performed with a constant voltage stimulator (Digitimer Ltd, Letchworth Garden City, UK) and a patch pipette (typically with a tip resistance of 4-6 MΩ ) filled with artificial cerebrospinal fluid and placed in the molecular layer adjacent to labeled parallel fibers. We monitored the fluorescence of single cerebellar PF boutons using continuous full-field imaging (~7 Hz). The extracellular stimulation intensity was increased until clear fluorescence responses were observed (threshold) after a train of 20-60 voltage pulses (60-μ s duration) at 100 or 300 Hz. The stimulus voltage was then increased by 5 V (above threshold) to ensure AP initiation for each stimulus pulse 14, 26 (see Supplementary Fig. 11 )
Line-scan fluorescence imaging of boutons was performed using a dwell time of 0.8-1.2 µ s per pixel for 300-800 ms. For a single bouton, multiple trials were performed at 0.5 Hz. The line scan was oriented perpendicular to the axon and bisected the bouton. Background fluorescence (F back ) was measured from 1-µ m regions of the line scan with the smallest fluorescence intensity that did not show any intensity increase during the electrical stimulation. Bouton fluorescence transients were averaged over a 0.5-1-µ m width of the line scan where an evoked transient occurred (transients were identified by eye from averaged linescan images (n = 10-50 trials). We corrected the fluorescence traces (F (t) ) for background by subtracting F back from the entire trace. For calculation of a ∆ F (t) /F 0 trace, F 0 was first calculated from the average of a 50-ms window of points before the stimulus and then subtracted from F (t) and used to scale the difference (see equation (1))
Analyses of amplitudes and time course were performed and trial-averaged traces underwent 10-point smoothing. Data were analyzed and presented using custom-written macros in Igor Pro. In order to analyze SF-iGluSnFR responses, we analyzed trials in which a fluorescence transient was detected. We deemed a response a 'success' if the peak of the fluorescence response was greater than three times the s.d. of the baseline fluorescence fluctuations. To do this, we compared the fluorescence value within a 20-ms window around the peak of each transient to the s.d. of fluorescence values calculated from a 20-ms baseline window on the trial-averaged transient.
The SNR was calculated from the ratio of the peak amplitude of the mean fluorescence trace and the s.d. of a 20-ms baseline window before the start of the electrical stimulation. The peak amplitude of the mean trace was estimated from the peak amplitude of a multi-exponential fit:
where t 0 is the start of the peak, τ rise is the rise time constant, τ 1 and τ 2 are the decay time constants, A max is the maximum amplitude in the trace, and A 1 and A 2 are constants that scaled the amplitude of the trace. Loading of Fluo-5F (400 µ M) was achieved using brief whole-cell recordings (1-2 min) of granule cells, after which the pipette was removed. Alexa Fluor 594 (10 µ M) was also included in the intracellular solution to identify loaded boutons. After a 15-min period to allow diffusion and equilibration of the dye, axonal stimulation was applied with an extracellular electrode. The stimulation electrode was positioned close (5-10 µ m) to the axon, and the intensity of a 50-µ s stimulation voltage pulse was progressively increased until a calcium transient was observed, indicating AP induction. For experiments we set the stimulation intensity 3-4 V above the first stimulation amplitude that generated a fluorescence transient.
The coefficient of variation of the peak of fluorescence responses was calculated from fluorescence traces that were corrected only for photomultiplier tube bias current (F r (t)) and using equation (3): The trial-averaged fluorescence transient (〈 F r (t)〉 ) and its variance (σ t ( ) F 2 ) were calculated from 50-70 trials (0.5 Hz) for each bouton. 〈 Δ F r 〉 is the mean peak amplitude calculated from a 20-ms window around the peak of 〈 F r (t)〉 corrected by the mean of a 20-ms baseline window before the start of the electrical stimulation. σ F 2 was calculated as the mean variance of σ t ( ) F 2 during the peak window. The dark noise (σ d 2 ) was measured without laser illumination. The final variance was estimated after subtraction of the expected increased variance due to photondependent shot-noise (σ sn 2 ), which itself was estimated by scaling of the fit (equation (2)) of 〈 F r (t)〉 scaled to the average value calculated from the baseline window of σ t ( )
Fast imaging of SF-Venus-iGluSnFR. Primary rat hippocampal neuron cultures.
A mixed cell culture (neurons and glia) was prepared from Sprague Dawley rat pups (Charles River Laboratories). Briefly, pups (male and female) at postnatal day 0 were decapitated, and the brains were dissected into ice-cold neural dissection solution (10 mM HEPES (Sigma) in HBSS (Invitrogen), pH 7.4). Hippocampi were dissected and cut into small pieces to facilitate enzyme digestion. Hippocampus pieces were transferred via a large-bore pipette into a 15-ml conical tube and incubated with enzyme digest solution (Papain, Worthington Biologicals) at 37 °C for 30 min. After 30 min, the enzyme solution was removed, plating media (MEM media containing 10% FBS) was added, and tissue pieces were triturated, which resulted in mostly single cells. The cell suspension was filtered with a 45-μ m filter. The filtered cell suspension was centrifuged, and the resulting cell pellet was resuspended with plating media and counted. For electroporation, 1 µ g of DNA was mixed with 1 × 10 6 cells using the Amaxa Nucleofector II instrument. Cells were plated onto coverslips coated with polyd-lysine (Sigma) and kept at 37 °C, 5% CO 2 in plating media for ~24 h, and then NbActiv4 (BrainBits) was added for the duration, with medium exchanges every 4 d.
Glutamate uncaging and imaging. Rat hippocampal culture was imaged on DIV 19 at room temperature in HEPES-buffered Tyrode's solution (145 mM NaCl, 2.5 mM KCl, 10 mM glucose, 10 mM HEPES, 2 mM CaCl 2 , 1 mM MgCl 2 , pH 7.4).
Excitation was applied with a 1,030-nm, 5-MHz, 190-fs laser (Menlo Systems; Bluecut). The average power was 39 mW at the sample. Fluorescence was collected at 560/80 nm with a Hamamatsu MPPC detector. The field of view was a 256-μ m-diameter circle 1,280 pixels across. The bath contained HEPES-buffered Tyrode's solution plus 10 µ M NBQX and 150 µ M RuBi-Glutamate (Tocris). Glutamate uncaging was performed with 420-nm fiber-coupled LEDs (Thorlabs; M420F2). The tips of the fibers were imaged onto the sample plane through the same objective used for activity imaging.
Imaging SF-Venus-iGluSnFR at 1,030 nm in vivo. All surgical procedures were in accordance with protocols approved by the HHMI Janelia Research Campus Institutional Animal Care and Use Committee (IACUC 17-155). An 8-week-old female C57BL/6NCrl mouse was anesthetized with isoflurane in oxygen and placed on a heated pad, and its head was gently affixed to a head holder by its front teeth. Buprenorphine HCl (0.1 mg/kg) and ketoprofen (5 mg/kg) were administered to the animal via subcutaneous injection. A 4.5-mm craniotomy (centered ~3.5 mm laterally and ~0.5 mm rostrally from lambda) was opened. We administered 6-8 injections (30 nl each, 1 nl/s, 300 µ m deep) of viral suspension containing AAV2/1.hSynapsin1.FLEX.SF-Venus-iGluSnFR.A184S (final titer: 5 × 10 11 GC/mL), AAV9.CaMKIIα.Cre (final titer: 5 × 10 11 gc/ml), final titer 1 × 10 7 gc/ml, to the left visual cortex. The craniotomy was closed with a 4-mm round coverslip that was fixed to the skull with cyanoacrylate glue. The recordings shown were obtained 12 weeks after surgery.
Imaging was performed with a custom-built two-photon microscope using ScanImage acquisition software (Vidrio Technologies), using 1,030-nm excitation (120 fs, 80 MHz; Insight DS+ , SpectraPhysics). The mouse was placed in a temperature-controlled plastic tube and its head was immobilized via headbar clamp beneath the water-immersed microscope objective, with a nose cone delivering 1% (vol/vol) isoflurane in oxygen. A vertically oriented screen (ASUS PA248Q LCD monitor, 1,920 × 1,200 pixels) was placed 17 cm from the right eye of the mouse, centered at 65° of azimuth and -10° of elevation. A high-extinction 500-nm shortpass filter (Wratten 47B-type) was affixed to the screen. Stimuli were drifting square-wave gratings (0.153 cycles per cm, 1 cycle s −1 , 2-s duration) in eight equally spaced directions, spaced by periods of mean luminance, as measured using the microscope detection path. Fluorescence was collected in two channels (500-580 nm and 595-685 nm) in a custom-built detection system. Isolated dendrites were imaged at 3.4 Hz. Images were aligned to compensate for bidirectional scanning and rolling-shutter motion artifacts using a series of stripwise registrations implemented in MATLAB code, available upon request. A region of interest was selected manually corresponding to a single dendritic spine. The baseline F 0 was calculated as the mean fluorescence intensity over 1 s before stimulus onset.
Simulations of glutamate diffusion. A finite differencing model was used to simulate diffusion of glutamate in water (diffusivity 700 μ m 2 /s), with an isotropic spatial resolution of 200 nm, from an initial distribution determined from a 3D intensity pattern that approximated the uncaging light pattern used in our experiments (5-μ m spot, 0.8 NA). A time step of 1.43 μ s was used, which ensured stability of the simulation with these parameters. The data were fit with custom MATLAB code (glutamateDiffusion.m), available upon request. Corresponding author(s): Loren L. Looger
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Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to determine sample size. Experiments were performed enough times to achieve consistent results and permit statistical analysis when appropriate.
Data exclusions
Describe any data exclusions. No data points were excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
No attempted replications failed. All experiments are shown.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization is not relevant to this study because no comparisons between experimental groups or treatments were made.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was performed because these experiments were performed to optimize and characterize a molecular toolset, not test a hypothesis.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
